We are live on ! Find out more
MRND

IQ U.S. Mid Cap R&D Leaders ETF
MRND

Delisted

MRND was delisted on the 12th of December, 2023.

Back to rankings

2 hedge funds and large institutions have $3.61M invested in IQ U.S. Mid Cap R&D Leaders ETF in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,705% more capital invested

Capital invested by funds: $200K → $3.61M (+$3.41M)

0% more funds holding

Funds holding: 2 → 2 (0)

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
NYLIM
1
New York Life Investment Management
New York
$3.6M – – –
UBS Group
2
UBS Group
Switzerland
$9K – – –

MRND Hedge Fund Activity: Q3 2022 in Review

2 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in IQ U.S. Mid Cap R&D Leaders ETF (MRND) for Q3 2022, worth a combined $3.61M — up 1,705% from $200K a quarter earlier.

Fund positioning in MRND was balanced in Q3 2022: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 2 institutional investors held IQ U.S. Mid Cap R&D Leaders ETF (MRND) as of Q3 2022, unchanged from Q2 2022.
  • Funds reported $3.61M of IQ U.S. Mid Cap R&D Leaders ETF stock for Q3 2022, up 1,705% quarter-over-quarter.
  • 0 funds opened new IQ U.S. Mid Cap R&D Leaders ETF positions in Q3 2022 and 0 closed out.

Based on aggregated 13F filings for Q3 2022.